Original paper

Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD)

Volume: 231, Pages: 108837 - 108837
Published: Oct 1, 2021
Abstract
RAS-associated autoimmune leukoproliferative disease (RALD) is a rare immune dysregulation syndrome caused by somatic gain-of-function mutations of either NRAS or KRAS gene in hematopoietic cells. We describe a 27-year-old patient presenting at 5 months of age with recurrent infections and generalized lymphadenopathy who developed a complex multi-organ autoimmune syndrome with hypogammaglobulinemia, partially controlled with oral steroids,...
Paper Details
Title
Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD)
Published Date
Oct 1, 2021
Volume
231
Pages
108837 - 108837
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.